"Even more importantly though is the "Halo" effect described by Wayne where 3D may get us into competitor accounts and open doors that were previously closed to us.
This also opens up exposure to our other Adapt products and has already (on a very small sample) shown that it has attracted interest in NEO where the surgeons were previously using a competitors product."
This to me is definitely the greatest benefit of CardioCel 3D and will be the main catalyst to an ongoing 'breakout' in all ADAPT products which our COO David St Denis said was already happening by the end of July, just his first month at Admedus and perhaps 2 months after CardioCel 3D first started being used....
Patience will be rewarded.
"Even more importantly though is the "Halo" effect described by...
-
- There are more pages in this discussion • 195 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.31 |
Change
-0.240(1.29%) |
Mkt cap ! $351.9M | |||
| Open | High | Low | Value | Volume |
| $18.80 | $19.15 | $18.20 | $159.7K | 8.611K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 73 | $18.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.33 | 90 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |